The Canadian Rheumatology Association (CRA) has recently issued a position statement asserting the need to provide empathetic and pragmatic guidance for patient care despite lack of evidence for use of medical cannabis in patients with rheumatic diseases.
Vitamin D deficiency in patients with rheumatoid arthritis (RA) may contribute to functional disability but exerts no effect on disease activity or inflammatory markers, a recent study from Malaysia has found.
First-line treatment with prednisolone (PSL) plus calcineurin inhibitor (CNI) has resulted in significantly better progression-free survival (PFS) in patients with aminoacyl-tRNA synthetase antibody–positive polymyositis/dermatomyositis-associated interstitial lung disease (ARS-PM/DM-ILD) compared with PSL monotherapy, according to a recent study. However, no significant difference is seen in terms of long-term survival among patients.
Patients with giant cell arteritis (GCA) receiving glucocorticoid (GC) plus methotrexate (MTX) have a nearly twofold lower rate of subsequent relapse compared to those taking GC alone, a study has shown.
In a US-based registry, only a few patients with psoriatic arthritis (PsA) on tumour necrosis factor inhibitor (TNFi) have achieved remission using the Clinical Disease Activity Index (CDAI) criteria, according to a new study, noting that female sex, obesity, comorbidities and education are associated with achieving remission.
Atrial fibrillation (AF) carries an excess risk of stroke recurrence independent of comorbidity with and heart failure (HF), while HF without AF also poses a significant risk of recurrence, a study has shown.
Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.